Study: Many cancer drugs remain unproven 5 years after approval
Honolulu Star-Advertiser - 2024-04-07T22:19:00.000Z

The U.S. Food and Drug Administration’s accelerated approval program is meant to give patients early access to promising drugs. But how often do these drugs actually improve or extend patients’ lives? Read this story